| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $5.02B | $4.73B | $4.36B |
| YoY Revenue Growth % | +6.1% | +8.4% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $2.05B | $2.40B | $1.31B |
| Operating Margin % | 40.8% | 50.7% | 30.0% |
| Net Income (GAAP) | $1.74B | $2.03B | $1.11B |
| EBITDA (Normalized) | $2.11B | $2.48B | $1.46B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $5.53B | -$486.0M | $2.63B |
| Capital Expenditures (CapEx) | $74.0M | $101.5M | $196.3M |
| Free Cash Flow (FCF) | $5.46B | -$587.5M | $2.43B |
| FCF Margin % | 108.8% | -12.4% | 55.7% |
| Return on Invested Capital (ROIC %) | 2.4% | 3.2% | 9.8% |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $73.88B | $64.22B | $4.07B |
| Total Stockholders' Equity | $12.96B | $12.79B | $8.35B |